This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) To 2017: Global Analysis

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Table of Contents

1. Executive Summary

2. Molecular Diagnostics Market & Forecast – (2010 – 2017)

3. Molecular Diagnostics Market Share – (2010 – 2017) 3.1 Molecular Diagnostics Market Share & Forecast – Application Wise3.2 Molecular Diagnostics Market Share & Forecast – Technology Wise3.3 Molecular Diagnostics Market Share & Forecast – Region Wise3.4 Molecular Diagnostics Market Share & Forecast – Company Wise

4. Molecular Diagnostics Market (Application Segment) – (2010 – 2017) 4.1 Infectious Disease Testing Market & Forecast4.1.1 Virology (HIV, HCV, HBV) Testing Market & Forecast4.1.2 Health – Associated Infections (HAI) Testing Market & Forecast4.1.3 HPV Testing Market & Forecast4.1.4 Critical Care Infectious Testing Market & Forecast4.2 Blood Screening Market & Forecast4.3 Genetic Testing Market & Forecast4.4 Oncology Testing Market & Forecast4.5 Tissue Typing (HLA Testing) Market & Forecast4.6 Cardiovascular Disease Testing Market & Forecast4.7 Neurological Disorders Testing Market & Forecast4.8 Food Pathogen Detection Testing Market & Forecast4.9 Miscellaneous Testing Market & Forecast

5. Molecular Diagnostics Market (Technologies Segment) – (2010 – 2017) 5.1 PCR Based Test Market & Forecast5.2 PCR Related Technologies Market & Forecast5.3 Non-PCR Test Market & Forecast5.4 Fish & Innovations Testing Market (Fluorescent in-situ hybridization) & Forecast5.5 Biochips/Microarrays Market & Forecast5.6 Biosensors Market & Forecast5.7 Molecular Imaging Market & Forecast5.8 Other Technologies Market & Forecast

6. Geographical Distribution – Molecular Diagnostics Market – (2008 – 2017) 6.1 United States Molecular Diagnostics Market & Forecast6.2 Europe Molecular Diagnostics Market & Forecast6.3 China Molecular Diagnostics Market & Forecast6.4 Japan Molecular Diagnostics Market & Forecast6.5 India Molecular Diagnostics Market & Forecast6.6 Brazil Molecular Diagnostics Market & Forecast6.7 Mexico Molecular Diagnostics Market & Forecast6.8 South Korea Molecular Diagnostics Market & Forecast6.9 Rest of World Molecular Diagnostics Market & Forecast

7. Molecular Diagnostics Market (Company Wise) – (2010 – 2017) 7.1 Roche Molecular Diagnostics Market & Forecast7.2 Abbott Molecular Diagnostics Market & Forecast7.3 Myriad Genetics Molecular Diagnostics Market & Forecast7.4 Qiagen Molecular Diagnostics Market & Forecast7.5 BioMérieux Molecular Diagnostics Market & Forecast7.6 Other Companies Molecular Diagnostics Market & Forecast

8. Molecular Diagnostics and Personalized Medicine8.1 Road to Personalized Medicine8.1.1 Historical perspective: HIV & Oncology8.1.2 Other Applications: Met & Unmet Therapy Areas

8.2 Molecular Diagnostics Technologies8.2.1 Expression Profiling - RNA & Pharmacogenomics8.2.2 Expression Profiling - Proteins & Pharmacoproteomics8.2.3 DNA Sequence Profiling - Pharmacogenetic & SNP Analysis8.2.4 DNA Sequence Profiling - High-Throughput Sequencing

3 of 8

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,880.36 -31.75 -0.19%
S&P 500 1,970.07 +0.12 0.01%
NASDAQ 4,462.9020 +20.2040 0.45%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs